Get access

Reply to Letter: Methods for assessing mortality in Parkinson's disease surveys

Authors

  • Ignacio J. Posada MD, PhD,

    1. Department of Neurology, University Hospital “12 de Octubre,” Madrid, Spain
    2. Faculty of Medicine, Complutense University, Madrid, Spain
    Search for more papers by this author
  • Julián Benito-León MD PhD,,

    Corresponding author
    1. Department of Neurology, University Hospital “12 de Octubre,” Madrid, Spain
    2. Faculty of Medicine, Complutense University, Madrid, Spain
    3. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
    • Department of Neurology, University Hospital “12 de Octubre,” Madrid, Spain
    Search for more papers by this author
  • Elan D. Louis MD, MSc,

    1. G.H. Sergievsky Center, College of Physicians and Surgeons Columbia University, New York, New York, USA
    2. Department of Neurology, College of Physicians and Surgeons, Columbia University New York, New York, USA
    3. Taub Institute for Research on Alzheimer's Disease and the Aging Brain College of Physicians and Surgeons, Columbia University, New York, New York, USA
    4. Department of Epidemiology, Mailman School of Public Health Columbia; University, New York, New York, USA
    Search for more papers by this author
  • Rocío Trincado MA,

    1. Department of Neurology, University Hospital “12 de Octubre,” Madrid, Spain
    2. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
    Search for more papers by this author
  • Alberto Villarejo MD,

    1. Department of Neurology, University Hospital “12 de Octubre,” Madrid, Spain
    2. Faculty of Medicine, Complutense University, Madrid, Spain
    Search for more papers by this author
  • José Medrano MD, PhD,

    1. Unit of Vascular Risk Factors, National Center for Epidemiology, ISCIII, Madrid, Spain
    Search for more papers by this author
  • Félix Bermejo-Pareja MD, PhD

    1. Department of Neurology, University Hospital “12 de Octubre,” Madrid, Spain
    2. Faculty of Medicine, Complutense University, Madrid, Spain
    3. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
    Search for more papers by this author

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary